Optimum Investment Advisors Amgen Inc Transaction History

Optimum Investment Advisors

$227 Million
Q3 2024

A detailed history of Optimum Investment Advisors transactions in Amgen Inc stock. As of the latest transaction made, Optimum Investment Advisors holds 1,286 shares of AMGN stock, worth $360,170. This represents 0.18% of its overall portfolio holdings.

Number of Shares

1,286

Previous 1,286 -0.0%

Holding current value

$360,170

Previous $401,000 3.24%

% of portfolio

0.18%

Previous 0.18%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	BUY	$268.87 - $324.56 $36,835 - $44,464	137 Added 11.92%	1,286 $365,000
Q4 2023 Jan 08, 2024	SELL	$255.7 - $288.46 $154,698 - $174,518	-605 Reduced 34.49%	1,149 $330,000
Q1 2023 May 03, 2023	SELL	$225.79 - $275.2 $39,513 - $48,160	-175 Reduced 9.07%	1,754 $424,000
Q4 2022 Jan 05, 2023	SELL	$229.03 - $291.01 $108,331 - $137,647	-473 Reduced 19.69%	1,929 $0
Q3 2022 Oct 24, 2022	SELL	$224.46 - $253.15 $78,561 - $88,602	-350 Reduced 12.72%	2,402 $541,000
Q1 2022 Apr 08, 2022	SELL	$219.27 - $242.57 $16,883 - $18,677	-77 Reduced 2.72%	2,752 $665,000
Q4 2021 Mar 17, 2022	SELL	$198.88 - $227.6 $11,932 - $13,656	-60 Reduced 2.08%	2,829 $636,000
Q3 2021 Oct 22, 2021	SELL	$212.27 - $248.7 $132,668 - $155,437	-625 Reduced 17.79%	2,889 $614,000
Q2 2021 Aug 02, 2021	SELL	$233.58 - $259.14 $297,814 - $330,403	-1,275 Reduced 26.62%	3,514 $857,000
Q4 2020 Jan 21, 2021	BUY	$216.38 - $257.67 $7,789 - $9,276	36 Added 0.76%	4,789 $1.1 Million
Q3 2020 Oct 06, 2020	BUY	$234.65 - $260.95 $7,039 - $7,828	30 Added 0.64%	4,753 $1.21 Million
Q2 2020 Jul 16, 2020	SELL	$197.81 - $242.74 $237,965 - $292,016	-1,203 Reduced 20.3%	4,723 $1.11 Million
Q1 2020 Apr 21, 2020	SELL	$182.24 - $241.7 $9,476 - $12,568	-52 Reduced 0.87%	5,926 $1.2 Million
Q4 2019 Jan 22, 2020	SELL	$189.21 - $243.2 $75,684 - $97,280	-400 Reduced 6.27%	5,978 $1.44 Million
Q3 2019 Oct 17, 2019	SELL	$174.11 - $208.62 $108,818 - $130,387	-625 Reduced 8.92%	6,378 $1.23 Million
Q1 2019 May 03, 2019	SELL	$180.87 - $203.88 $23,513 - $26,504	-130 Reduced 1.82%	7,003 $1.33 Million
Q4 2018 Feb 04, 2019	SELL	$178.4 - $208.25 $24,084 - $28,113	-135 Reduced 1.86%	7,133 $1.39 Million
Q3 2018 Oct 05, 2018	SELL	$185.29 - $208.89 $99,130 - $111,756	-535 Reduced 6.86%	7,268 $1.51 Million
Q4 2017 Jan 16, 2018	SELL	$168.79 - $188.59 $18,735 - $20,933	-111 Reduced 1.4%	7,803 $1.36 Million
Q3 2017 Nov 21, 2017	BUY	$167.29 - $191.0 $38,476 - $43,930	230 Added 2.99%	7,914 $1.48 Million
Q2 2017 Aug 14, 2017	BUY	N/A	7,684	7,684 $1.32 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Optimum Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Optimum Investment Advisors with notifications on news.

Account

Optimum Investment Advisors Amgen Inc Transaction History